A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia.

Miller, John

A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia. [electronic resource] - AIDS (London, England) Nov 2002 - 2195-200 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial

0269-9370

10.1097/00002030-200211080-00012 doi


Diet
Double-Blind Method
Female
Gemfibrozil--adverse effects
HIV Infections--drug therapy
HIV Protease Inhibitors--adverse effects
Humans
Hypertriglyceridemia--chemically induced
Hypolipidemic Agents--adverse effects
Male
Middle Aged
Treatment Outcome